Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1961 2
1962 3
1963 7
1964 19
1965 20
1966 17
1967 29
1968 11
1969 15
1970 15
1971 18
1972 27
1973 22
1974 18
1975 29
1976 21
1977 25
1978 26
1979 12
1980 25
1981 25
1982 30
1983 32
1984 28
1985 37
1986 26
1987 29
1988 35
1989 33
1990 40
1991 28
1992 36
1993 37
1994 24
1995 38
1996 20
1997 19
1998 29
1999 17
2000 18
2001 28
2002 36
2003 42
2004 34
2005 40
2006 52
2007 49
2008 43
2009 52
2010 56
2011 58
2012 65
2013 76
2014 87
2015 109
2016 104
2017 112
2018 135
2019 154
2020 178
2021 179
2022 203
2023 73
Text availability
Article attribute
Article type
Publication date

Search Results

2,661 results
Results by year
Filters applied: . Clear all
Page 1
Ruxolitinib for the treatment of graft-versus-host disease.
Ali H, Salhotra A, Modi B, Nakamura R. Ali H, et al. Among authors: nakamura r. Expert Rev Clin Immunol. 2020 Apr;16(4):347-359. doi: 10.1080/1744666X.2020.1740592. Epub 2020 Apr 1. Expert Rev Clin Immunol. 2020. PMID: 32153201 Review.
A BCMA/CD16A bispecific innate cell engager for the treatment of multiple myeloma.
Kakiuchi-Kiyota S, Ross T, Wallweber HA, Kiefer JR, Schutten MM, Adedeji AO, Cai H, Hendricks R, Cohen S, Myneni S, Liu L, Fullerton A, Corr N, Yu L, de Almeida Nagata D, Zhong S, Leong SR, Li J, Nakamura R, Sumiyoshi T, Li J, Ovacik AM, Zheng B, Dillon M, Spiess C, Wingert S, Rajkovic E, Ellwanger K, Reusch U, Polson AG. Kakiuchi-Kiyota S, et al. Among authors: nakamura r. Leukemia. 2022 Apr;36(4):1006-1014. doi: 10.1038/s41375-021-01478-w. Epub 2022 Jan 10. Leukemia. 2022. PMID: 35001074
Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Saad A, de Lima M, Anand S, Bhatt VR, Bookout R, Chen G, Couriel D, Di Stasi A, El-Jawahri A, Giralt S, Gutman J, Ho V, Horwitz M, Hsu J, Juckett M, Kharfan-Dabaja MA, Loren A, Meade J, Mielcarek M, Moreira J, Nakamura R, Nieto Y, Roddy J, Satyanarayana G, Schroeder M, Tan CR, Tzachanis D, Burn J, Pluchino L. Saad A, et al. Among authors: nakamura r. J Natl Compr Canc Netw. 2020 May 1;18(5):599-634. doi: 10.6004/jnccn.2020.0021. J Natl Compr Canc Netw. 2020. PMID: 32519831
Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages.
Feurstein S, Trottier AM, Estrada-Merly N, Pozsgai M, McNeely K, Drazer MW, Ruhle B, Sadera K, Koppayi AL, Scott BL, Oran B, Nishihori T, Agrawal V, Saad A, Lindsley RC, Nakamura R, Kim S, Hu Z, Sobecks R, Spellman S, Saber W, Godley LA. Feurstein S, et al. Among authors: nakamura r. Blood. 2022 Dec 15;140(24):2533-2548. doi: 10.1182/blood.2022015790. Blood. 2022. PMID: 35969835
Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation-Associated Thrombotic Microangiopathy.
Khaled SK, Claes K, Goh YT, Kwong YL, Leung N, Mendrek W, Nakamura R, Sathar J, Ng E, Nangia N, Whitaker S, Rambaldi A; OMS721-TMA-001 Study Group Members. Khaled SK, et al. Among authors: nakamura r. J Clin Oncol. 2022 Aug 1;40(22):2447-2457. doi: 10.1200/JCO.21.02389. Epub 2022 Apr 19. J Clin Oncol. 2022. PMID: 35439028 Free PMC article. Clinical Trial.
Large-scale manufacturing and characterization of CMV-CD19CAR T cells.
Wang X, Urak R, Walter M, Guan M, Han T, Vyas V, Chien SH, Gittins B, Clark MC, Mokhtari S, Cardoso A, Diamond DJ, Zaia J, Forman SJ, Nakamura R. Wang X, et al. Among authors: nakamura r. J Immunother Cancer. 2022 Jan;10(1):e003461. doi: 10.1136/jitc-2021-003461. J Immunother Cancer. 2022. PMID: 35027426 Free PMC article.
Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia.
Aldoss I, Otoukesh S, Zhang J, Mokhtari S, Ngo D, Mojtahedzadeh M, Al Malki MM, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Koller P, Ball B, Stewart F, Curtin P, Artz A, Nakamura R, Marcucci G, Forman SJ, Stein AS, Pullarkat V. Aldoss I, et al. Among authors: nakamura r. Cancer. 2022 Feb 1;128(3):529-535. doi: 10.1002/cncr.33967. Epub 2021 Oct 11. Cancer. 2022. PMID: 34633671 Free article.
Boosting healthier choices.
Rouyard T, Engelen B, Papanikitas A, Nakamura R. Rouyard T, et al. Among authors: nakamura r. BMJ. 2022 Jan 4;376:e064225. doi: 10.1136/bmj-2021-064225. BMJ. 2022. PMID: 34983778 Free PMC article.
2,661 results